Table 1.
The XP docking scores, MM-GBSA estimations and experimental free energies (kcal/mol) of compounds 1–5 and reference drugs (indomethacin, and diclofenac) with COX-1, COX-2, and 5-LOX proteins.
Compounds | COX-1 | COX-2 | 5-LOX | ||||||
---|---|---|---|---|---|---|---|---|---|
GlideScore (kcal/mol) | Free energy (kcal/mol) | GlideScore (kcal/mol) | Free energy (kcal/mol) | GlideScore (kcal/mol) | Free energy (kcal/mol) | ||||
XP | MM-GBSA | exp | XP | MM-GBSA | exp | XP | MM-GBSA | exp | |
1 | − 7.3 | − 9.9 | − 6.3 | − 9.3 | − 30.6 | − 6.5 | − 7.8 | − 18.4 | − 6.2 |
2 | − 8.0 | 5.6 | − 6.2 | − 9.4 | − 15.1 | − 6.4 | − 7.1 | − 34.0 | − 6.3 |
3 | − 10.1 | − 15.0 | − 6.8 | − 10.2 | − 36.8 | − 6.9 | − 5.2 | − 42.1 | − 6.5 |
4 | − 10.1 | − 57.7 | − 6.9 | − 9.6 | − 39.2 | − 7.0 | − 6.1 | − 35.1 | − 6.3 |
5 | − 10.2 | − 55.3 | − 6.7 | − 9.9 | − 38.9 | − 6.9 | − 5.3 | − 50.0 | − 6.5 |
Indomethacin | − 9.6 | − 47.5 | − 6.8 | − 4.0 | − 29.1 | − 6.9 | − 5.7 | − 45.0 | ND |
Diclofenac | − 6.2 | − 12.6 | ND | − 8.9 | − 49.6 | ND | − 7.3 | − 26.6 | − 6.3 |
ND Not done.